Cyclophosphamide is a type of antineoplastic medication, which is commonly used in chemotherapy and immunosuppressive therapy. It requires metabolic activation to function as an alkylating agent, meaning it is not cytotoxic in its initial state.
The Australian Veterinary Association (AVA) was not consulted prior to last week’s public announcement of the Victorian Government’s intention to merge the Veterinary Practitioners Registration Board of Victoria (VPRBV) into a new Business and Professions Regulator as part of the recommendations in the Silver Review. The AVA has serious concerns in relation to this intention and is liaising with the VPRBV.
From 1 December 2025, new Occupational Health and Safety (Psychological Health) Regulations will come into effect in Victoria and will directly impact veterinary practices across the state.
The AVA recently met with Assistant Minister for Primary Industry Development, Water and Western Queensland, Sean Dillon MP. The meeting provided a valuable opportunity to progress discussions on several key […]
The AVA has been actively advocating for a review of the Veterinary Surgeons Act 1936 – legislation that is now almost 90 years old and no longer reflects the modern veterinary profession or its needs.
The AVA is pleased to share the below communication from Biosecurity Queensland regarding the launch of the Priority EAD Sample Transport Subsidy pilot.
This week, final year Murdoch School of Veterinary Medicine students attended an inspiring event to learn how they can be supported through the AVA Graduate Mentoring Program in their transition into the veterinary profession.
Murdoch University is inviting veterinarians in clinical practice, both metro or rural, across companion animal, equine, production, and mixed practice—to participate in a review of the School of Veterinary Medicine’s Problem List and Skills List, important contributors to the veterinary curriculum
Fresh and existing content is coming soon – stay tuned!
